PL178094B1 - Nowe pochodne 5-hydrazynochinolonu o działaniu przeciwdrobnoustrojowym - Google Patents

Nowe pochodne 5-hydrazynochinolonu o działaniu przeciwdrobnoustrojowym

Info

Publication number
PL178094B1
PL178094B1 PL93308671A PL30867193A PL178094B1 PL 178094 B1 PL178094 B1 PL 178094B1 PL 93308671 A PL93308671 A PL 93308671A PL 30867193 A PL30867193 A PL 30867193A PL 178094 B1 PL178094 B1 PL 178094B1
Authority
PL
Poland
Prior art keywords
compound
quinolone
mixture
mol
cyclopropyl
Prior art date
Application number
PL93308671A
Other languages
English (en)
Polish (pl)
Other versions
PL308671A1 (en
Inventor
Thomas P. Demuth Jr.
Ronald E. White
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PL308671A1 publication Critical patent/PL308671A1/xx
Publication of PL178094B1 publication Critical patent/PL178094B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL93308671A 1992-10-30 1993-10-22 Nowe pochodne 5-hydrazynochinolonu o działaniu przeciwdrobnoustrojowym PL178094B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96896092A 1992-10-30 1992-10-30
PCT/US1993/010091 WO1994010163A1 (en) 1992-10-30 1993-10-22 Antimicrobial 5-hydrazino-quinolone derivatives

Publications (2)

Publication Number Publication Date
PL308671A1 PL308671A1 (en) 1995-08-21
PL178094B1 true PL178094B1 (pl) 2000-02-29

Family

ID=25514997

Family Applications (1)

Application Number Title Priority Date Filing Date
PL93308671A PL178094B1 (pl) 1992-10-30 1993-10-22 Nowe pochodne 5-hydrazynochinolonu o działaniu przeciwdrobnoustrojowym

Country Status (21)

Country Link
EP (1) EP0666853A1 (pt)
JP (1) JPH08502750A (pt)
KR (1) KR950704301A (pt)
CN (1) CN1064357C (pt)
AU (1) AU687018B2 (pt)
BR (1) BR9307347A (pt)
CA (1) CA2148003A1 (pt)
CZ (1) CZ282581B6 (pt)
EG (1) EG20543A (pt)
FI (1) FI952049A7 (pt)
HU (1) HUT72072A (pt)
IL (1) IL107323A (pt)
MX (1) MX9306814A (pt)
NO (1) NO951640L (pt)
NZ (1) NZ257470A (pt)
PL (1) PL178094B1 (pt)
RU (1) RU2126000C1 (pt)
SG (1) SG59979A1 (pt)
SK (1) SK54795A3 (pt)
WO (1) WO1994010163A1 (pt)
ZA (1) ZA938089B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
CA2196539C (en) * 1994-08-02 2001-05-15 The Procter & Gamble Company Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
WO1996004247A1 (en) * 1994-08-02 1996-02-15 The Procter & Gamble Company Process for making antimicrobial compounds
ATE229950T1 (de) * 1996-02-09 2003-01-15 Toyama Chemical Co Ltd Chinolin carbonsaure-derivate und ihre salze
RU2248199C1 (ru) * 2003-06-02 2005-03-20 Открытое Акционерное Общество "Акционерное Курганское общество медицинских препаратов и изделий "Синтез" (ОАО "Синтез") Глазные капли и способ их получения
RU2265437C2 (ru) * 2003-07-02 2005-12-10 Суханов Александр Владимирович Способ лечения заболеваний желудка и двенадцатиперстной кишки, вызванных helicobacter pylori
RU2245134C1 (ru) * 2003-09-02 2005-01-27 Открытое акционерное общество "Красфарма" Состав офлоксацина для инъекций
WO2005026147A1 (ja) 2003-09-10 2005-03-24 Kyorin Pharmaceutical Co., Ltd. 7−(4−置換−3−シクロプロピルアミノメチル−1−ピロリジニル)キノロンカルボン酸誘導体
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP2594272B1 (en) * 2005-05-18 2018-07-11 Horizon Orphan LLC Aerosolized fluoroquinolones and uses thereof
CA2528849C (en) 2005-06-08 2014-01-14 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents
EA010601B1 (ru) * 2005-06-09 2008-10-30 Янссен Фармацевтика Н.В. Производные хинолина в качестве антибактериальных агентов
CN101020647B (zh) * 2007-02-14 2011-03-30 杭州师范学院 一种β-环丙胺基丙烯酸(酯)的合成方法
JP5363350B2 (ja) * 2007-03-19 2013-12-11 武田薬品工業株式会社 Mapk/erkキナーゼ阻害剤
US7928100B2 (en) * 2007-10-05 2011-04-19 Cylene Pharmaceuticals, Inc. Quinolone analogs and methods related thereto
MX2010012855A (es) * 2008-06-03 2010-12-21 Actelion Pharmaceuticals Ltd Derivados de [4-(1-amino-etil)-ciclohexil]-metil-amina y [6-(1-amino-etil)-tetrahidro-piran-3-il]-metil-amina como antibacterianos.
KR101959873B1 (ko) 2008-10-07 2019-03-19 랩터 파마슈티컬스 인코포레이티드 약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
AR076222A1 (es) * 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
WO2011029059A1 (en) 2009-09-04 2011-03-10 Mpex Pharmaceuticals, Inc. Use of aerosolized levofloxacin for treating cystic fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
WO1991002526A1 (en) * 1989-08-16 1991-03-07 Pfizer Inc. Azabicyclo quinolone carboxylic acids
ES2147721T3 (es) * 1990-04-18 2000-10-01 Procter & Gamble Pharma Quinolonil lactamas antimicrobianas.
DK0559774T3 (da) * 1990-11-30 2000-01-31 Warner Lambert Co Individuelle stereoisomerer af 7-/3-(1-aminoalkyl)-1-pyrrolidinal/-quinoloner og naphthyridoner som antibakterielle midler

Also Published As

Publication number Publication date
IL107323A0 (en) 1994-01-25
WO1994010163A1 (en) 1994-05-11
HU9501237D0 (en) 1995-06-28
MX9306814A (es) 1994-07-29
AU5409794A (en) 1994-05-24
BR9307347A (pt) 1999-05-25
NO951640L (no) 1995-06-30
PL308671A1 (en) 1995-08-21
RU2126000C1 (ru) 1999-02-10
AU687018B2 (en) 1998-02-19
CN1064357C (zh) 2001-04-11
CN1092773A (zh) 1994-09-28
CA2148003A1 (en) 1994-05-11
IL107323A (en) 2000-06-01
SG59979A1 (en) 1999-02-22
CZ109795A3 (en) 1995-12-13
ZA938089B (en) 1994-06-07
JPH08502750A (ja) 1996-03-26
EG20543A (en) 1999-07-31
RU95110762A (ru) 1997-01-10
NO951640D0 (no) 1995-04-28
FI952049A0 (fi) 1995-04-28
EP0666853A1 (en) 1995-08-16
NZ257470A (en) 1997-08-22
HUT72072A (en) 1996-03-28
KR950704301A (ko) 1995-11-17
CZ282581B6 (cs) 1997-08-13
FI952049L (fi) 1995-04-28
FI952049A7 (fi) 1995-04-28
SK54795A3 (en) 1995-12-06

Similar Documents

Publication Publication Date Title
PL178094B1 (pl) Nowe pochodne 5-hydrazynochinolonu o działaniu przeciwdrobnoustrojowym
KR100256457B1 (ko) 항미생물성 퀴놀론 티오우레아
AU2005316668B2 (en) Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors
US5646163A (en) Quinolone 5-(N-heterosubstituted amino) antimicrobials
JP2002507610A (ja) イミダゾロン食欲抑制薬:iii.ヘテロアリール誘導体
KR20000005238A (ko) 세펨 화합물 및 그 화합물을 함유하는 약제
EP0677050B1 (en) Novel pyridone carboxylic acid derivatives
EP0115049B1 (en) 1-ethyl-6,8-difluoro-1,4-dihydro-7-(1-imidazolyl)-4-oxoquinoline-3-carboxylic acid derivatives, process for preparing the same and anti-microbial compositions
US5281613A (en) Heterocyclic compounds
US7109190B2 (en) Carbacephem β-lactam antibiotics
JP3477466B2 (ja) キノリンカルボン酸誘導体又はその塩
JPH06199835A (ja) 8−ジフルオロメトキシキノリン−3−カルボン酸誘導体
KR100628414B1 (ko) 퀴놀린카르복실산 유도체 또는 그의 염
JP2007525417A (ja) 新規化合物
JPWO2001017991A1 (ja) キノリンカルボン酸誘導体又はその塩
JPH06145167A (ja) 8−メトキシ−5−メチルキノリン−3−カルボン酸誘導体
AU2002327182A1 (en) Novel heterocyclic antibacterial compounds
JPH0413355B2 (pt)
JPH0892241A (ja) 5−ヒドラジノキノロンカルボン酸誘導体及びこれを有効成分とする抗菌剤
JPH0649060A (ja) 5−アミノ−7−(5−アザスピロ〔2,4〕ヘプタン−5−イル)キノリン−3−カルボン酸誘導体
JPH0219380A (ja) キノロンカルボン酸化合物
JPH0616676A (ja) 5,8−ジハロゲノチアゼトキノリン−3−カルボン酸誘導体
IL92092A (en) Dithiocarbamoyl quinolones and pharmaceutical compositions containing them
HU211332A9 (hu) Mikrobaellenes ditiokarbamoil-kinolonok Az átmeneti oltalom a(z) 1*29. igénypontra vonatkozik.
HU211319A9 (hu) Mikrobaellenes kinolon-tiokarbamidok Az átmeneti oltalom az 1-22. igénypontokra vonatkozik.